openPR Logo
Press release

Lemborexant API Market Expands as Demand for Sleep Disorder Treatments Grows | Valuates Reports

04-03-2025 08:54 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: Valuates Reports

Lemborexant API Market
The global Lemborexant API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.

View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-6M17581/Global_Lemborexant_API_Market_Research_Report_2024

Lemborexant API Market Trends

The Lemborexant API market is experiencing significant expansion due to the increasing prevalence of sleep disorders such as insomnia. As a dual orexin receptor antagonist, Lemborexant is widely used in pharmaceutical formulations for treating chronic sleep-related conditions, offering an alternative to traditional sedative-hypnotics. The growing awareness of sleep health, coupled with rising diagnoses of insomnia and other sleep disorders, is driving demand for Lemborexant Active Pharmaceutical Ingredients (API).

In terms of market share, North America leads the market, driven by high healthcare spending, an aging population, and the widespread adoption of advanced sleep medications. Meanwhile, Asia-Pacific is emerging as a fast-growing region, fueled by increasing research and development activities, expanding pharmaceutical manufacturing capabilities, and rising consumer awareness of sleep disorder treatments. Pharmaceutical companies are focusing on improving formulation techniques and optimizing production processes to enhance market penetration.

From a market analysis perspective, revenue in the Lemborexant API market is projected to grow steadily as pharmaceutical firms continue to develop new insomnia treatment drugs. Regulatory approvals and patent exclusivity play a crucial role in shaping market dynamics. Additionally, increasing investments in sleep medicine research, expanding distribution networks, and strategic partnerships between API manufacturers and drug developers are expected to sustain market growth in the coming years.

by Type

• Purity≥98%
• Purity≥99%

by Application

• Pharmaceutical
• Scientific Research

By Company

Teva Pharmaceutical Industries, Valiant, Qingmu Pharmaceutical

View full report
https://reports.valuates.com/market-reports/QYRE-Auto-6M17581/global-lemborexant-api

Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066,

Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Lemborexant API Market Expands as Demand for Sleep Disorder Treatments Grows | Valuates Reports here

News-ID: 3953088 • Views:

More Releases from Valuates Reports

Lithium Battery Multilayer Separator Market Share Driven by Growing Demand for P …
Lithium Battery Multilayer Separator Market The global market for Lithium Battery Multilayer Separator was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period. View sample report https://reports.valuates.com/request/sample/QYRE-Auto-17V15093/Global_Lithium_Battery_Multilayer_Separator_Market_Research_Report_2023 The Lithium Battery Multilayer Separator market is gaining strong momentum, driven by the rapid expansion of electric mobility, renewable energy storage, and advanced consumer electronics. Multilayer
RGV & AMR for Semiconductor Fab Market Share Driven by Automation in 200mm and 3 …
RGV & AMR for Semiconductor Fab. Market Size The global market for RGV & AMR for Semiconductor Fab. was valued at US$ 226 million in the year 2024 and is projected to reach a revised size of US$ 348 million by 2031, growing at a CAGR of 6.9% during the forecast period. View sample report https://reports.valuates.com/request/sample/QYRE-Auto-8V18055/Global_RGV_AMR_for_Semiconductor_Fab_Market_Research_Report_2024 The RGV & AMR for Semiconductor Fab market is witnessing significant growth, fueled by the increasing adoption of
Laser Grooving Equipment for Semiconductor Market Share Driven by Wafer and Sola …
Laser Grooving Equipment for Semiconductor Market Size The global market for Laser Grooving Equipment for Semiconductor was valued at US$ 468 million in the year 2024 and is projected to reach a revised size of US$ 810 million by 2031, growing at a CAGR of 9.2% during the forecast period. View sample report https://reports.valuates.com/request/sample/QYRE-Auto-37P10426/Global_Laser_Grooving_Equipment_for_Semiconductor_Market_Research_Report_2022 The Laser Grooving Equipment for Semiconductor market is experiencing strong growth, driven by the increasing demand for precise and efficient
Semiconductor Wafer Bonding Equipment Market Share Driven by MEMS and Advanced P …
Semiconductor Wafer Bonding Equipment Market Size The global market for Semiconductor Wafer Bonding Equipment was valued at US$ 318 million in the year 2024 and is projected to reach a revised size of US$ 448 million by 2031, growing at a CAGR of 5.1% during the forecast period. View sample report https://reports.valuates.com/request/sample/QYRE-Auto-20O11268/Global_Semiconductor_Wafer_Bonding_Equipment_Market_Research_Report_2022 The Semiconductor Wafer Bonding Equipment market is experiencing robust growth, driven by rising demand for high-precision wafer bonding in MEMS, advanced packaging,

All 5 Releases


More Releases for Lemborexant

Chronic Insomnia Market to Expand Significantly by 2034, States DelveInsight Rep …
The Chronic Insomnia market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Chronic Insomnia pipeline products will significantly revolutionize the Chronic Insomnia market dynamics. DelveInsight's "Chronic Insomnia Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Chronic Insomnia, historical and forecasted epidemiology as well as the Chronic Insomnia market trends in the United States,
Obstructive Sleep Apnea Pipeline | 20+ Key Players & 20+ Pipeline Drugs | FDA, E …
DelveInsight's, "Obstructive Sleep Apnea Pipeline Insight 2023" report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Obstructive Sleep Apnea (OSA) pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Key takeaways from the Obstructive Sleep Apnea Pipeline
Insomnia Treatment Market is expected to be valued at around US$ 7.5 Bn by 2026 …
Insomnia Treatment Market 2022 The global market for insomnia treatment is expected to be valued at around US$ 7.5 Bn by 2026 end, witnessing steady expansion at 5.2% CAGR over 2018-2026. Get Free Sample Copy Of Insomnia Treatment Market Report@ https://www.persistencemarketresearch.com/samples/23203 Technological innovations have revolutionized lifestyle, communication, business, travel, and healthcare. The healthcare technology industry is continually improving ways to treat neural-related medical conditions, coupled with a significant understanding of subsequent ramifications and consequences. On the
Lemborexant – Drug Launch Insight, 2018
Lemborexant was discovered by Eisai Co. Ltd. in-house scientists. It is a novel investigational small molecule inhibiting orexin signaling by binding competitively to both orexin receptors subtypes (receptor 1 and 2). In January 2019, Eisai Co. Ltd. and Purdue Pharma L.P. submitted a new drug application (NDA) to the United States Food and Drug Administration (USFDA) for sleep-wake regulation. Download the sample report at: https://www.pharmaproff.com/request-sample/1160 Both the companies are actively seeking drug’s
Insomnia Treatment Market to Touch US$ 7.5 Bn by 2026 end
Technological innovations have revolutionized lifestyle, communication, business, travel, and healthcare. The healthcare technology industry is continually improving ways to treat neural-related medical conditions, coupled with a significant understanding of subsequent ramifications and consequences. On the other hand, the pharmaceutical landscape has also transitioned and opened itself to explore novel scientific approaches and innovative technologies within its core therapeutic areas. To know key findings Request Sample Report @: https://www.persistencemarketresearch.com/samples/23203 New Pharmaceutical Innovations to
Innovations in Healthtech and Pharma to Redefine Treatment for Insomnia
Technological innovations have revolutionized lifestyle, communication, business, travel, and healthcare. The healthcare technology industry is continually improving ways to treat neural-related medical conditions, coupled with a significant understanding of subsequent ramifications and consequences. On the other hand, the pharmaceutical landscape has also transitioned and opened itself to explore novel scientific approaches and innovative technologies within its core therapeutic areas. Request to Sample Report @ https://www.persistencemarketresearch.com/samples/23203 New Pharmaceutical Innovations to Address Key